Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics


Por: Julve, J, Martin-Campos, JM, Escola-Gil, JC, Blanco-Vaca, F

Publicada: 1 abr 2016
Resumen:
The adequate absorption of lipids is essential for all mammalian species due to their inability to synthesize some essential fatty acids and fat-soluble vitamins. Chylomicrons (CMs) are large, triglyceride-rich lipoproteins that are produced in intestinal enterocytes in response to fat ingestion, which function to transport the ingested lipids to different tissues. In addition to the contribution of CMs to postprandial lipemia, their remnants, the degradation products following lipolysis by lipoprotein lipase, are linked to cardiovascular disease. In this review, we will focus on the structure function and metabolism of CMs. Second, we will analyze the impact of gene defects reported to affect CM metabolism and, also, the role of CMs in other pathologies, such as atherothrombotic cardiovascular disease and diabetes mellitus. Third, we will provide an overview of the laboratory tests currently used to study CM disorders, and, finally, we will highlight current treatments in diseases affecting CMs. (C) 2016 Elsevier B.V. All rights reserved.

Filiaciones:
Julve, J:
 IIB St Pau, Inst Recerca IHSCSP, Barcelona 08025, Spain

 Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain

 CIBER Diabet & Enfermedades Metabol Asociadas, Barcelona, Spain

Martin-Campos, JM:
 IIB St Pau, Inst Recerca IHSCSP, Barcelona 08025, Spain

 Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain

 CIBER Diabet & Enfermedades Metabol Asociadas, Barcelona, Spain

Escola-Gil, JC:
 IIB St Pau, Inst Recerca IHSCSP, Barcelona 08025, Spain

 Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain

 CIBER Diabet & Enfermedades Metabol Asociadas, Barcelona, Spain

Blanco-Vaca, F:
 IIB St Pau, Inst Recerca IHSCSP, Barcelona 08025, Spain

 Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain

 CIBER Diabet & Enfermedades Metabol Asociadas, Barcelona, Spain

 Hosp Santa Creu & Sant Pau, Servei Bioquim, Barcelona, Spain
ISSN: 00098981





CLINICA CHIMICA ACTA
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Review
Volumen: 455 Número:
Páginas: 134-148
WOS Id: 000373655100024
ID de PubMed: 26868089

MÉTRICAS